Inhibition of ACSS2-mediated histone crotonylation alleviates kidney fibrosis via IL-1β-dependent macrophage activation and tubular cell senescence
Lingzhi Li(Affiliated Hospital of Southwest Medical University), Liang Ma(Guangdong Pharmaceutical University), Ping Fu(Shandong Center for Disease Control and Prevention), Yiting Wu(Sichuan University), Han Feng(Tulane University), Fan Guo(Sichuan University), Ting Xiang(Sichuan University), Sibei Tao(Sichuan University), Jing Liu(Gansu University of Traditional Chinese Medicine), Jingjing Guo(First Affiliated Hospital of Henan University of Science and Technology)
Cited by 88
Related Papers
Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA
|Cell Research|2011|1.2k
Kidney fibrosis: from mechanisms to therapeutic medicines
|Signal Transduction and Targeted Therapy|2023|646
Understanding the gut–kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition
|Acta Diabetologica|2019|183
The Nuclear Receptor ESRRA Protects from Kidney Disease by Coupling Metabolism and Differentiation
|Cell Metabolism|2020|171
Gut microbiota–derived short-chain fatty acids and kidney diseases
|Drug Design Development and Therapy|2017|157